Article

Wilmer Eye Institute teaches leadership by example

The Wilmer Eye Institute at Johns Hopkins University School of Medicine, Baltimore, may be based near the nation's capital but, since its earliest days, the institute has considered its primary mission to improve eye care throughout the world.

Key Points

Founded in 1925 by a group of philanthropists and headed by William Holland Wilmer, MD, the institute has strived to contribute to ophthalmic knowledge and reduce suffering at home and around the world through research, education, and patient care. And, for more than a decade, the institute has led national rankings among eye institutions, including Ophthalmology Times' annual Best Programs survey.

"Every single candidate was in the top 1% of medical students for their year," he said. "It's almost an impossible task to choose among this group of stellar students. To me it really is encouraging for the future of our specialty."

With such an accomplished group of candidates, future residents must be more than good students. They must possess a "creative spark" and leadership skills that could be nurtured so that they, in turn, go on to become leaders within ophthalmology, Dr. McDonnell added.

And there is a great tradition of that. An astounding 102 trainees have gone on to be department chairpersons, he said, along with countless faculty members who have passed through the institution. Still others have left the Wilmer Eye Institute to start strong private practices or ground-breaking private enterprises, such as David R. Guyer, MD, whose company developed the first FDA-approved treatment for wet age-related macular degeneration.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.